Western Sydney University has received over $700,000 from the Medical Research Future Fund to determine whether new diabetes technology can reduce pregnancy complications for women with type 1 diabetes. The project is titled “Closed-loop Insulin delivery by glucose Responsive Computer algorithms In Type 1 diabetes pregnancies (CIRCUIT)” and aims to test Automated Insulin Delivery (AID) technology. The research will be led by Distinguished Professor David Simmons and Associate Professor Kathy Tannous from the School of Medicine and Translational Health Research Institute. The Canadian team led by Professor Lois Donovan in Calgary will collaborate on the study funded by the Canadian Institutes of Health Research. Automated insulin delivery technology can provide a better and more accurate way to mimic healthy pancreas function by adjusting the amount of insulin infused by a small pump, based on current and predicted glucose levels. If successful, the findings could lead to more effective and easier ways for women with type one diabetes to have healthier pregnancies and children. The Medical Research Future Fund is a $20 billion long-term investment supporting Australian health and medical research, and it aims to transform health and medical research and innovation to improve lives, build the economy, and contribute to health system sustainability.
Western Sydney University Awarded Funding for Diabetes Technology Research
Western Sydney University has been awarded over $700,000 by the Medical Research Future Fund (MRFF) in the Clinical Trials Collaboration Round. The funds will be used to determine whether new diabetes technology can reduce pregnancy complications among women with type 1 diabetes.
Distinguished Professor David Simmons and Associate Professor Kathy Tannous from the School of Medicine and Translational Health Research Institute (THRI) will lead the project, titled “Closed-loop Insulin delivery by glucose Responsive Computer algorithms In Type 1 diabetes pregnancies (CIRCUIT)”. The research aims to tackle complications for newborns resulting from elevated glucose in pregnancy by testing a new technology called Automated Insulin Delivery (AID).
The team will investigate whether the technology results in better glucose control, reduced diabetes self-care demands and fewer neonatal and maternal complications compared to conventional insulin delivery. The project’s lead investigator, Professor David Simmons, believes that the findings could lead to more effective and easier ways for women with type one diabetes to have healthier pregnancies and children.
The funding received by Western Sydney University is a part of the Medical Research Future Fund (MRFF), a $20 billion long-term investment supporting Australian health and medical research. The MRFF aims to transform health and medical research and innovation to improve lives, build the economy and contribute to health system sustainability.
Deputy Vice-Chancellor (Research, Enterprise & International) Professor Deborah Sweeney welcomed the funding, stating that the development of this technology is set to have life-changing impacts on pregnant mothers and their babies. Western Sydney University aims to leverage its research excellence and strategic alliances to address such a complex global health challenge.
Automated insulin delivery technology can provide a better and more accurate way to mimic healthy pancreas function by adjusting the amount of insulin infused by a small pump, based on current and predicted glucose levels. This could not only help achieve normal glucose levels but significantly improve a mother’s quality of life at a time when it should be one of the most joyous.
Collaboration with Canadian Team for Diabetes Technology Study
The study to test new diabetes technology for pregnant women with type 1 diabetes will be carried out in collaboration with a team in Canada led by Professor Lois Donovan in Calgary. The Canadian team is funded by the Canadian Institutes of Health Research.
Don’t miss interesting posts on Famousbio
